The influence of alendronate on bone formation and resorption in a rat ectopic bone development model

Journal of Periodontology

Volumn 74, Issue 1, 2003, Pages 44-50

  Yaffe, Avinoam ^a   Kollerman, Ron ^b   Bahar, Hila ^c   Binderman, Itzhak ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alendronate therapeutic use; Bisphosphonates; Bone loss prevention and control; Bone marrow; Bone reconstruction; Bone regeneration; Bone resorption prevention and control

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMUR; HISTOLOGY; IMAGE ANALYSIS; MALE; MICRORADIOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; RAT;

ALENDRONATE; ANALYSIS OF VARIANCE; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE MARROW; BONE RESORPTION; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MALE; MICRORADIOGRAPHY; OSSIFICATION, HETEROTOPIC; OSTEOBLASTS; OSTEOGENESIS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; SKIN; STATISTICS; TIME FACTORS;

EID: 0037262005     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.1.44     Document Type: Article

References (29)

1. Binderman I. Bone and biologically compatible materials in dentistry. Curr Opin Dent 1991;1:836-840.
2. Hanada K, Dennis JE, Caplan AI. Stimulatory effect of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12:1606-1614.
3. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Gehron Robey P. In vivo bone formation by human bone marrow stromal cells: Effect of carrier particle size and shape. Biotechnol Bioeng 2001;72:96-107.
4. Dahir GA, Cui Q, Anderson P, et al. Pluripotential mesenchymal cells repopulate bone marrow and retain osteogenic properties. Clin Orthop 2000;379(Suppl): S134-S145.
5. Lino M, Ishii H, Sato J, Seto K. Histologic evaluation of autogenous iliac particulate cancellous bone and marrow grafted to alveolar cleft-a preliminary report of five young adult cases. Cleft Palate Craniofac J 2000;37:55-60.
6. Hiatt WH, Schallhorn RG, Aaronian AJ. The induction of new bone and cementum formation. IV. Microscopic examination of periodontium following human bone and marrow allograft, autograft and nongraft periodontal regenerative procedure. J Periodontol 1978;49:495-512.
7. Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin Orthop Rel Res 1987;225:7-15.
8. Urist MR. Bone formation by autoinduction. Science 1965;15:893-899.
9. Urist MR, Sato K, Brownwell A, et al. Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 1983;173:194-199.
10. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68:884-889.
11. Yaffe A, Fine N, Alt I, Binderman I. Effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
12. Schenk R, Eggli P, Fleisch H, Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 1986;38:342-349.
13. Kaynak D, Meffert R, Gunhan M, Gunhan O, Ozkaya O. A histopathological investigation on effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 2000;71:790-796.
14. Sato M, Grasser W, Endo E, et al. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991;88:2095-2105.
15. 3H-etidronate in rat and mouse bones. Bone 1996;19:281-290.
16. Adami S, Zamberlan M, Mian M, et al. Duration of the effect of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. Bone Miner 1994;25:75-82.
17. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-1443.
18. Nimni ME, Bernick S, Ertl D, et al. Ectopic bone formation is enhanced in senescent animals implanted with embryonic cells. Clin Orthop Rel Res 1988;234:255-266.
19. Bahar H, Yaffe A, Binderman I. The influence of nacre surface and its modification on bone apposition, in a bone development model, in rats. J Periodontol 2003; in press.
20. Gabriel L. Videodensitometrical study of the alveolar bone crest in periodontal disease. J Periodontol 1991; 62:528-534.
21. Lepola V, Jalovaara P, Väänänen K. The influence of clodronate on the torsional strength of the growing rat tibia in immobilization osteoporosis. Bone 1994;15:367-371.
22. Thompson DD, Seedor JG, Weinreb M, Rosini S, Rodan GA. Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats. J Bone Miner Res 1990;5:279-280.
23. Nishikawa M, Akatsu T, Katayama Y, et al. Bisphosphonates act on osteoblastic cells inhibit osteoclast formation in mouse marrow cultures. Bone 1996;18:9-14.
24. Renholtz GG, Getz B, Pederson L, et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000;60:6001-6007.
25. Valkema R, Vismans FJFE, Papapoulos SE, Pauwels EKJ, Bijovoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183-192.
26. Rodan GA. Bone mass homeostasis and bisphosphonate action. Bone 1977;20:1-4.
27. Patalas N, Golomb G, Yaffe T, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999;60:68-73.
28. Fleisch H. Experimental basis for the use of bisphosphonates in Paget's disease of bone. Clin Orthop Rel Res 1987;217:72-78.
29. Azuma Y, Sato H, Oue Y, et al. Alendronate distribution on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia model. Bone 1995;16:235-245.